🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Another paper affiliated from the Faculty of Medicine of KUL, John Paul II Catholic University of Lublin on the recent advances in primary and secondary #cardiovascular #prevention. We discuss here the concept of the #lifetime #CVD #riskstratification comparing different available #risk #scores. For the first

Have you already booked your time for the 10th Anniversary Meeting of the International Lipid Expert Panel International Lipid Expert Panel (ILEP) ? 💪 Stay Tuned for the next info🥰

Amazing news ‼️ Our joint analysis on the role of endothelial IGFBP6 in the suppression of vascular inflammation and atherosclerosis has just been released in the nature Cardiovascular Research 💪 Within this analysis we identify insulin-like growth factor binding protein 6

mp.pl/kurier/370819,…

Prof. Maciej Banach: fakultatywność całkowicie wypacza ideę #edukacjazdrowotna. Jak mamy być skuteczni w leczeniu społeczeństwa, skoro go nie edukujemy? Ministerstwo Edukacji Narodowej Barbara Nowacka Iza Leszczyna✌️🇵🇱 Ministerstwo Zdrowia 👉tiny.pl/1c0hnqb4

Our Expert Opinion article on the extended indications for #fenofibrate in prevention of #cardiovascular #complications, and specifically #retinopathy is a cover article of the new issue of the Archives of Medical Science (AMS). This was a tremendous work of the experts representing different

Dr.Amit Archives of Medical Science (AMS) Stanisław Surma Grzegorz Dzida Andrzej Grzybowski Jacek Rysz Uniwersytet Opolski Instytut CZMP Diabetic Retinopathy Diabetic Retinopathy American Diabetes Association Int. Diabetes Fed. archivesofmedicalscience.com/The-prevention…

Pewnie pamiętacie nasza analizę, która była jedna z najbadziej cytowanych w światowych mediach (Altmetric score 6280) prac w 2023 roku o roli kroków w wydłużaniu życia, w której powiedzieliśmy, ze dla osób względnie zdrowych, bez choroby sercowo-naczyniowej korzystny efekt

IMPORTANT from the new issue of Archives of Medical Science (AMS): 2024 Polish #recommendations for the #management of #familial #hypercholesterolemia #FH in #children and #adolescents. The most important recommendations: 👉 It is advisable to use direct #LDL #cholesterol #measurement for improved

Pamietam nasza najwieksza na świecie meta-analizę (640,000 osób), która oceniała wpływ produktów mlecznych na zgon bez względu na przyczynę, zgony sercowo-naczyniowe i inne punkty końcowe. Wówczas wykazaliśmy, ze produkty pochodzenia mlecznego w diecie maja korzystny wpływ na

Important paper on the trends on #aspirin use in primary and secondary prevention in US. The trend is stable in 2ndary prevention based on guidelines, but it was significantly reduced (what is not a surprise) in primary prevention especially in older patients >70 years of age for

Feel invited to join us at the 4th World Congress of Clinical Lipidology in Vienna! Karam Kostner

The results of our data from the #PMMHRI-#LPA #Registry and #STAR-#LPA study that were presented at the European Society of Cardiology #congress in London again beautifully summarized in the MSN. Thanks! msn.com/en-gb/health/o…

❗️❗️❗️

A look to the past – what has had the biggest impact on lipids in the last four decades? A personal perspective archivesofmedicalscience.com/A-look-to-the-…

Very important meeing pf EU-RO Forum on #Diabetes and its #complications in Bucharest organized by Prof. Anca Stoian. Thanks for the Invitation💪

On Thursday I was in Ljubljana at the Transcutaneous Contemporary Interventions-Coronaries (#TCICoronaries) Meeting, where within interventional cardiologists I presented the newest data on the #upfront lipid lowering combination #therapy in #ACS patients. Our data from the

Our recent, just published in #EHJOpen journal by the European Society of Cardiology , largest ever #metaanalysis on #FH #children #patients, showed not only a large efficacy of #lipid lowering #therapy #LLT, especially combination one, but it also clearly showed that #statin/lipid lowering therapy

Why #upfront #lipid lowering combination #therapy should to be a GOLD standard in the management of #patients with high and very high #cardiovascular #disease #risk? Why we need to change the paradigm of short-term #risk #stratification (to 👉 lifetime risk stratification) and

We have just started the 2nd day of the #ILEP2025 Congress in Warsaw. The first session is dedicated to #statin #therapy💪 #ArmanPostadzhiyan #ZlatkoFras Gani Bajraktari Stanisław Surma International Lipid Expert Panel (ILEP)